Clinical trial
The Adherence of Immunosuppressive Therapy Including Tacrolimus Once Daily in a Cohort of Kidney Transplant Recipients: an Italian Prospective Observational Study
NCT03558373 is registered in ClinicalTrials.gov with Chiesi Farmaceutici S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Adherence of Immunosuppressive Therapy Including Tacrolimus Once Daily in a Cohort of Kidney Transplant Recipients: an Italian Prospective Observational Study
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2018
- Completion date
- February 26, 2020
- Enrollment
- 158 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplant